Flexbumin is a Intravenous Injection, Solution in the Plasma Derivative category. It is labeled and distributed by Baxalta Us Inc.. The primary component is Albumin Human.
| Product ID | 0944-0495_22af2f71-74f4-4a01-99fb-bc9878174ff8 |
| NDC | 0944-0495 |
| Product Type | Plasma Derivative |
| Proprietary Name | Flexbumin |
| Generic Name | Albumin Human |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2014-07-31 |
| Marketing Category | BLA / BLA |
| Application Number | BLA101452 |
| Labeler Name | Baxalta US Inc. |
| Substance Name | ALBUMIN HUMAN |
| Active Ingredient Strength | 0 g/mL |
| Pharm Classes | Human Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2014-07-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA101452 |
| Product Type | PLASMA DERIVATIVE |
| Billing Unit | ML |
| Marketing Start Date | 2014-07-31 |
| Ingredient | Strength |
|---|---|
| ALBUMIN HUMAN | .05 g/mL |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0944-0493 | FLEXBUMIN | Albumin Human |
| 0944-0495 | Flexbumin | Albumin Human |
| 67467-623 | Albumin (Human) | Albumin Human |
| 67467-633 | Albumin (Human) | Albumin Human |
| 67467-643 | Albumin (Human) | Albumin Human |
| 68982-623 | Albumin (Human) | Albumin Human |
| 68982-633 | Albumin (Human) | Albumin Human |
| 68982-643 | Albumin (Human) | Albumin Human |
| 64208-2510 | ALBUMINEX | Albumin Human |
| 64208-2512 | ALBUMINEX | Albumin Human |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() FLEXBUMIN 78122148 3083369 Live/Registered |
BAXALTA INCORPORATED 2002-04-16 |